Oral Bisphosphonates, Osteonecrosis, and Dental Implants
Dr. Gold submits:
About 80 million people in the US alone take bisphosphonates for
cancer, osteoperosis, etc. It is clear that patients who have received
IV bisphosphonates are at high risk for osteonecrosis in the mandible
and maxilla.
What is not clear is the situation for patients who have taken bisphosphonates via the oral route. Not as much data has been collected on oral bisphosphonates and osteonecrosis and dental implant failure. However, the evidence for is mounting daily that orally administered forms of bisphosphonates may lead to osteonecrosis. What does this imply for dental implant placement in these cases?
Are you familiar with any anecdotal case reports of patients who have take oral bisphosphonates and experienced osteonecrosis associated with dental implant failure? What are your thoughts on the connection between Oral Bisphosphonates, Osteonecrosis, and Dental Implants? Please leave your comments below.
Note: For additional discussion on this topic, please also see Dental Implant Contraindications where we discuss IV bisphosphonates in greater length.